Botox Shots Approved for Migraine

Friday, October 15, 2010 - 23:00 in Mathematics & Economics

Allergan, Botox’s maker, recently agreed to pay $600 million to settle allegations that it had illegally marketed the drug for unapproved uses like headaches for years.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net